Adam Smith Conferences would like to thank all participants – speakers, sponsors and delegates – for contributing to the great success of the recent Adam Smith Conferences’ 14th Russian Pharmaceutical Forum.

Once again, the Adam Smith RUSSIAN PHARMACEUTICAL FORUM underlined its status as the premier gathering of senior industry professionals working in Russia. Close to 400 attendees took part over the 3 days of the Forum, where all the burning industry issues were discussed.

As always, the pharma community particularly appreciated the opportunity to hear from the 50-strong speaker faculty, which featured senior executives from such admired companies as:

Alliance Healthcare * Association of the Russian Pharmaceutical Manufacturers * Comcon-Pharma * CV "PROTEK" * Doctor Stoletov * DSM Group * GlaxoSmithKline Export Ltd * Hoffman la Roche * IMS-Health * STADA * Novartis Consumer Health * Nycomed Russia-CIS * Otechestvennye Lekarstva * Pharmacy Chain 36.6 * Pharmexpert * Pharmstandart * Polskie Lekarstva * Ratiopharm RUS LLC * Rigla * RMBC * Rosta Group * Roszdvravnadzor * Sandoz Russia * Servier Russia * Teva Pharmaceutical Industries * Unique Pharmaceutical Laboratories/ J. B.Chemicals & Pharmaceuticals...and many others!

This year’s Forum offered many new features, including:

• 3 KEYNOTE PRESENTATIONS:

“Choosing the right business model for the future. How can established success be maintained in the pharmaceutical sector? What are the critical long-term success factors?” by Jostein Davidsen, General Director, Nycomed Russia-CIS
“Investor perspective on the current investment climate and attractiveness of the Russian pharmaceutical sector” by Dmitriy Efimov, General Director, Nizhpharm and Vice President STADA
Emerging Markets Current Status and Future Directions by Tuygan Goker, Regiona Head- CEMAI, Hoffman la Roche

• CEO PANEL DISCUSSION: a unique opportunity for the audience to raise the most burning issues, challenges and topics, and to discuss them on the day with some of the industry’s top pharmaceutical CEOs . The panel was moderated by Serge Scotto, Regional Director for Russia, CIS and Balkans, IMS Health and featured: 
  
  Michael Crow, General Manager, GlaxoSmithKline Export Ltd, Jostein Davidsen, General Director, Nycomed Russia-CIS,  Jere Calmes, President, Pharmacy Chain 36.6, Aleksey Molchanov, General Director, CV "PROTEK" and Dmitriy Efimov, General Director, Nizhpharm and Vice President STADA

• SPECIAL FOCUS PANEL - “One Hour with the Regulators”: The aim of this session was to provide an in-depth understanding of the main areas of the pharmaceutical industry regulation in Russia, and to focus on the practical aspects of industry relations with the Government in the region.  The panel was moderated by Vladimir Shipkov, Executive Director, AIPM and features such Government Officials as: Dmitry Reikhardt, Acting Director, Federal Obligatory Medical Insurance Fund , Elena Telnova, Deputy Head, Roszdravnadzor, Andrei Mladentsev, Deputy Head, Roszvravnadzor, Sergey Tsyb, Director, Department  of Chemical-Engineering and Bioengineering  Technologies, Мinistry of Industry and Trade of the Russian   Federation and Arkadiy Feferman, General Director, Centre  for Expertise and Quality Control of  Healthcare Products 

• Another well received by all the delegates feature of the programme was LIVE SPOTLIGHT INTERVIEW: with Patrick Aghanian, General Manager, Sandoz Russia, offering the chance to hear in-depth insight into strategic directions of one of the largest pharmaceutical companies in Russia, as well as further perspectives on market developments. The interview was held by Maria Bailey, Reporter, Central and Eastern Europe, Scrip World Pharmaceutical News, Informa Healthcare. You can download more detailed information and the interview transcript here

• ANALYTICAL MARKET FORECAST PANEL - “The Russian Pharmaceutical Sector expectations for 2008 and beyond? “ gave all the delegates an opportunity to discuss ideas, outlooks, and forecasts for 2008 and analyse possible scenarios for future development of the sector with such market experts as: Nick Demidov, General Director, Pharmexpert; Marina Denisova, General Director, RMBC; Alexander Kuzin, General Director, DSM Group and Alina Lavrentieva, Director, Tax & Legal Services, PricewaterhouseCoopers

All of these new elements were extremely well-received, and we are already planning new ideas for 2009!

Once again, particular thanks go to the sponsors of the conference for making it all possible!

LEAD SPONSOR: Pharmexpert,
MASTER CLASS SPONSOR: Ernst &Young;
SPONSORS: DSM, RMBC, PricewaterhouseCoopers, Cegedim Dendrite, RIA Panda, CMS Cameron McKenna, UBS Investment Bank, Publicis United Healthcare, Baker & McKenzie LLP, Rosno, IPNET and Vita Media

We look forward to shortly informing you about the preparations for the Adam Smith Conferences’ Russian Pharmaceutical Forum– 2008. For all enquiries regarding the event, including your preferences regarding the dates and venue, please write to Jane Gelfand at JaneG@adamsmithconferences.com.

If you did not have a chance to participate in this outstanding event, but want to access the presentations, you can purchase the conference documentation here.